Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

112.40EUR
11:35am EDT
Change (% chg)

€0.50 (+0.45%)
Prev Close
€111.90
Open
€111.35
Day's High
€112.40
Day's Low
€111.25
Volume
1,494,108
Avg. Vol
1,878,172
52-wk High
€123.90
52-wk Low
€86.03

Chart for

About

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The... (more)

Overall

Beta: 0.98
Market Cap(Mil.): €93,363.84
Shares Outstanding(Mil.): 826.95
Dividend: 2.70
Yield (%): 2.41

Financials

  Industry Sector
P/E (TTM): -- 31.24 15.93
EPS (TTM): -- -- --
ROI: -- 15.06 14.60
ROE: -- 16.31 13.96

BRIEF-Bayer ‍appoints Sharon James Head of Global Innovation & Development for Consumer Health

* ‍APPOINTS SHARON JAMES HEAD OF GLOBAL INNOVATION & DEVELOPMENT FOR CONSUMER HEALTH​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Sep 22 2017

Bayer says needs more time for Monsanto deal approval

MONHEIM, Germany German drugs and pesticides group Bayer said on Tuesday it was now likely to be early next year before it can complete its $66 billion deal to acquire U.S. group Monsanto , later than previously expected.

Sep 19 2017

EU agrees to extend deadline for decision on Bayer, Monsanto deal

BRUSSELS The European Commission said on Tuesday it has approved German drugs and pesticides group Bayer's request for an extension of the investigation into the $66 billion deal to acquire U.S. group Monsanto .

Sep 19 2017

EU agrees to extend deadline for decision on Bayer, Monsanto deal

BRUSSELS, Sept 19 The European Commission said on Tuesday it has approved German drugs and pesticides group Bayer's request for an extension of the investigation into the $66 billion deal to acquire U.S. group Monsanto .

Sep 19 2017

Bayer dismisses antitrust concerns about digital farming

MONHEIM, Germany Bayer said it was unable to propose the sale of any digital farming assets to allay EU concerns about its planned $66 billion takeover of Monsanto .

Sep 19 2017

UPDATE 2-Bayer says needs more time for Monsanto deal approval

* Crop Science unit says global market remain volatile in '17

Sep 19 2017

UPDATE 1-Bayer dismisses antitrust concerns about digital farming

* Bayer says fails to see how to address digital farming concerns

Sep 19 2017

Bayer dismisses antitrust concerns about digital farming

FRANKFURT, Sept 19 Bayer said it was unable to propose the sale of any assets to allay the European Commission's concerns about potential dominance in agricultural markets that could stem from the use of digital farm management tools.

Sep 19 2017

BRIEF-EU to decide "shortly" on Bayer request for Monsanto extension

* to decide shortly on Bayer request for Monsanto anti-trust review deadline extension Further company coverage: (Reporting By Georgina Prodhan)

Sep 19 2017

Bayer says needs more time for Monsanto deal approval

MONHEIM, Germany, Sept 19 German drugs and pesticides maker Bayer said it would likely take until early next year to complete the planned $66 billion takeover of U.S. seeds group Monsanto, which it had previously expected to be under wraps by the end of 2017.

Sep 19 2017

Earnings vs. Estimates